"Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial" 
Lancet Jun 12
http://www.lancet.com/journals/laninf/article/PIIS1473-3099(13)70149-X/fulltext
"Interpretation

Boceprevir in combination with peginterferon—ribavirin could be an important therapeutic option for patients with HCV and HIV.
FundingMerck."